Literature DB >> 20136840

Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat.

E Ekundi-Valentim1, K T Santos, E A Camargo, A Denadai-Souza, S A Teixeira, C I Zanoni, A D Grant, Jl Wallace, M N Muscará, S K Costa.   

Abstract

BACKGROUND AND
PURPOSE: Recent findings suggest that the noxious gas H(2)S is produced endogenously, and that physiological concentrations of H(2)S are able to modulate pain and inflammation in rodents. This study was undertaken to evaluate the ability of endogenous and exogenous H(2)S to modulate carrageenan-induced synovitis in the rat knee. EXPERIMENTAL APPROACH: Synovitis was induced in Wistar rats by intra-articular injection of carrageenan into the knee joint. Sixty minutes prior to carrageenan injection, the rats were pretreated with indomethacin, an inhibitor of H(2)S formation (DL-propargylglycine) or an H(2)S donor [Lawesson's reagent (LR)]. KEY
RESULTS: Injection of carrageenan evoked knee inflammation, pain as characterized by impaired gait, secondary tactile allodynia of the ipsilateral hindpaw, joint swelling, histological changes, inflammatory cell infiltration, increased synovial myeloperoxidase, protein nitrotyrosine residues, inducible NOS (iNOS) activity and NO production. Pretreatment with LR or indomethacin significantly attenuated the pain responses, and all the inflammatory and biochemical changes, except for the increased iNOS activity, NO production and 3-NT. Propargylglycine pretreatment potentiated synovial iNOS activity (and NO production), and enhanced macrophage infiltration, but had no effect on other inflammatory parameters. CONCLUSIONS AND IMPLICATIONS: Whereas exogenous H(2)S delivered to the knee joint can produce a significant anti-inflammatory and anti-nociceptive effect, locally produced H(2)S exerts little immunomodulatory effect. These data further support the development and use of H(2)S donors as potential alternatives (or complementary therapies) to the available anti-inflammatory compounds used for treatment of joint inflammation or relief of its symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136840      PMCID: PMC2850403          DOI: 10.1111/j.1476-5381.2010.00640.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

Review 1.  Work disability in rheumatic diseases.

Authors:  Edward Yelin
Journal:  Curr Opin Rheumatol       Date:  2007-03       Impact factor: 5.006

2.  Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB.

Authors:  Huili Zhang; Liang Zhi; Shabbir Moochhala; Philip K Moore; Madhav Bhatia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-01-05       Impact factor: 5.464

3.  Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative.

Authors:  Ling Li; Giuseppe Rossoni; Anna Sparatore; Lin Chiou Lee; Piero Del Soldato; Philip Keith Moore
Journal:  Free Radic Biol Med       Date:  2006-12-16       Impact factor: 7.376

4.  Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis.

Authors:  Benjamin Andruski; Donna-Marie McCafferty; Teegan Ignacy; Brandie Millen; Jason J McDougall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

5.  Dual role of hydrogen sulfide in mechanical inflammatory hypernociception.

Authors:  Thiago M Cunha; Daniela Dal-Secco; Waldiceu A Verri; Ana T Guerrero; Guilherme R Souza; Silvio M Vieira; Celina M Lotufo; Alberto F Neto; Sergio H Ferreira; Fernando Q Cunha
Journal:  Eur J Pharmacol       Date:  2008-06-07       Impact factor: 4.432

6.  Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats.

Authors:  Lin Chang; Bin Geng; Fang Yu; Jing Zhao; Hongfeng Jiang; Junbao Du; Chaoshu Tang
Journal:  Amino Acids       Date:  2007-12-11       Impact factor: 3.520

Review 7.  Hydrogen sulfide-releasing anti-inflammatory drugs.

Authors:  John L Wallace
Journal:  Trends Pharmacol Sci       Date:  2007-09-19       Impact factor: 14.819

8.  Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase.

Authors:  Satoko Kubo; Yuko Kurokawa; Ichiko Doe; Takashi Masuko; Fumiko Sekiguchi; Atsufumi Kawabata
Journal:  Toxicology       Date:  2007-08-19       Impact factor: 4.221

9.  Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling.

Authors:  Nathan L Whitfield; Edward L Kreimier; Francys C Verdial; Nini Skovgaard; Kenneth R Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-16       Impact factor: 3.619

Review 10.  Hydrogen sulphide and its therapeutic potential.

Authors:  Csaba Szabó
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

View more
  28 in total

1.  Sulphide quinone reductase contributes to hydrogen sulphide metabolism in murine peripheral tissues but not in the CNS.

Authors:  D R Linden; J Furne; G J Stoltz; M S Abdel-Rehim; M D Levitt; J H Szurszewski
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Hydrogen sulfide: a gasotransmitter of clinical relevance.

Authors:  M Scott Vandiver; Solomon H Snyder
Journal:  J Mol Med (Berl)       Date:  2012-03       Impact factor: 4.599

Review 3.  Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury.

Authors:  John L Wallace; Jose G P Ferraz; Marcelo N Muscara
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

Review 4.  Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter.

Authors:  John L Wallace; Rui Wang
Journal:  Nat Rev Drug Discov       Date:  2015-04-07       Impact factor: 84.694

5.  Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.

Authors:  Weijun Wu; Ming Qin; Wanwan Jia; Zheng Huang; Zhongzheng Li; Di Yang; Mengwei Huang; Chenxi Xiao; Fen Long; Jianchun Mao; Philip K Moore; Xinhua Liu; Yi Zhun Zhu
Journal:  Cell Mol Immunol       Date:  2018-05-29       Impact factor: 11.530

Review 6.  H2S and its role in redox signaling.

Authors:  Omer Kabil; Nicole Motl; Ruma Banerjee
Journal:  Biochim Biophys Acta       Date:  2014-01-11

7.  P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.

Authors:  Juliana Maia Teixeira; Franciane Bobinski; Carlos Amílcar Parada; Kathleen A Sluka; Cláudia Herrera Tambeli
Journal:  Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.590

Review 8.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

9.  Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis.

Authors:  M Li; Jian-Chun Mao; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

Authors:  Zhen Liu; Yi Han; Ling Li; Hui Lu; Guoliang Meng; Xiaozhen Li; Mohammed Shirhan; Meng Teng Peh; Liping Xie; Suming Zhou; Xiaowei Wang; Qi Chen; Weilu Dai; Choon-Hong Tan; Shiyang Pan; Philip K Moore; Yong Ji
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.